# US 2026/0250668 A1 · Cytidine deaminases and methods of use in mapping modified cytosine nucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0250668 A1
- Document ID: US20260250668A1
- Status: Published application
- Kind: A1
- Application number: 18/879,473
- Filed: 2023-09-29
- Published: 2026-08-27
- Earliest claimed: 2022-09-30
- Assignees: Illumina, Inc.
- Applicants: Illumina, Inc.
- Inventors: Gaetano Speciale
- Web page: https://patentgrep.com/patent/US20260250668A1

## CPC

- C12N 9/78: acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12N 9/2497: {hydrolysing N- glycosyl compounds (3.2.2)}
- C12N 9/58: derived from fungi
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Y 302/02027: Uracil-DNA glycosylase (3.2.2.27)
- C12Y 305/04005: Cytidine deaminase (3.5.4.5)
- C12Y 304/21064: Peptidase K (3.4.21.64)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

The present disclosure is concerned with proteins, methods, compositions, and kits for mapping of methylation status of nucleic acids. In one embodiment, proteins are provided that selectively act on certain modified cytosines of target nucleic acids and converts them to thymine. Also provided are compositions and kits that include one or more of the proteins and methods for using one or more of the proteins.

## Claims

### Claim 1

A method for identifying methylated nucleotides comprising:
providing a sample of DNA suspected of comprising at least one 5-methyl cytosine (5mC);
contacting the sample with a cytidine deaminase;
contacting the sample with an uracil-DNA glycosylase (UDG) to result in modified DNA; and
processing the modified DNA to produce a sequencing library.

### Claim 2 (depends on 1)

The method of claim 1, wherein the UDG is a Family IV UDG.

### Claim 3 (depends on 1)

The method of claim 1, wherein the UDG comprises a KRRIH motif (SEQ ID NO: 81).

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The method of claim 1, further comprising treating the sample with a protease.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The method of claim 1, further comprising contacting the sample with a nucleophile in a solvent.

### Claim 8 (depends on 7)

The method of claim 7, wherein the nucleophile comprises an azide moiety, and wherein contacting the sample with a nucleophile yields a glycosyl azide.

### Claim 9

(canceled)

### Claim 10 (depends on 7)

The method of claim 7, wherein the nucleophile comprises a cytosine analog.

### Claim 11 (depends on 10)

The method of claim 10, wherein the nucleophile comprises a compound of Formula (II):
wherein R1 is N, C, O, or S,
wherein each R2 is independently H or A-R3,
wherein A is alkyl, preferably CH2(2),
wherein R3 is —NH2, —ONH2, —SH, or —OH, and
wherein n is 2, 3, or 4.

### Claim 12 (depends on 11)

The method of claim 11, wherein the nucleophile comprises a compound of Formula (IIA), Formula (IIB), or Formula (IIC):
wherein R1 is N, C, O, or S,
wherein R3 is —NH2, —ONH2, —SH, or —OH.

### Claim at position 13

-15. (canceled)

### Claim 16 (depends on 7)

The method of claim 7, further comprising contacting the sample with an electrophile.

### Claim 17 (depends on 16)

The method of claim 16, wherein the electrophile comprises an alkyne.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The method of claim 1, further comprising:
providing a surface comprising a plurality of amplification sites, wherein the amplification sites comprise at least two populations of attached single-stranded capture oligonucleotides having a free 3′ end; and
contacting the surface comprising amplification sites with the sequencing library under conditions suitable to produce a plurality of amplification sites that each comprise a clonal population of amplicons from an individual member of the sequencing library.

### Claim 20 (depends on 19)

The method of claim 19, further comprising sequencing the library; and
interpreting the results to identify methylated nucleotides.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 1)

The method of claim 1, wherein the method further comprises, before the providing, denaturing double-stranded DNA present in the sample to result in single-stranded DNA.

### Claim 24 (depends on 1)

The method of claim 1, wherein the sample is a biological sample.

### Claim 25 (depends on 24)

The method of claim 24, wherein the biological sample comprises cell-free DNA.

### Claim at position 24

-30. (canceled)

### Claim 31 (depends on 1)

The method of claim 1, wherein the cytidine deaminase is an altered cytidine deaminase comprising an amino acid substitution mutation at a position functionally equivalent to (Tyr/Phe)130 in a wild-type APOBEC3A protein.

### Claim 32 (depends on 31)

The method of claim 31, wherein the substitution mutation at the position functionally equivalent to Tyr130 comprises a mutation to Ala, Val, or Trp.

### Claim 33 (depends on 31)

The method of claim 31, wherein the altered cytidine deaminase comprises amino acid substitution mutations at positions functionally equivalent to (Tyr/Phe)130 and Tyr132 in a wild-type APOBEC3A protein.

### Claim 34

(canceled)

### Claim 35 (depends on 31)

The method of claim 31, wherein the altered cytidine deaminase comprises a ZDD motif H-[P/A/V]-E-X[23-28]-P-C-X[2-4]-C (SEQ ID NO: 12).

### Claim 36

(canceled)
